Notice of Rulings

Administered by Department of the Treasury

Legislation au C2020G00656 In force Gazette

Legislation content

The Commissioner of Taxation, Chris Jordan, gives notice of the following Rulings, copies of which can be obtained from ato.gov.au/law.

NOTICE OF RULINGS

Ruling number

Subject

Brief description

TR 2020/4

Income tax:  thin capitalisation – the arm’s length debt test

This Ruling provides guidance on the application of the arm’s length debt test contained in the thin capitalisation rules in Division 820 of the Income Tax Assessment Act 1997.

This Ruling applies before and after its issue date.

CR 2020/42

Nova Eye Medical Limited – return of capital

This Ruling sets out the tax consequences for shareholders who received a return of capital from Nova Eye Medical Limited on 29 July 2020.

This Ruling applies from 1 July 2020 to 30 June 2021.

CR 2020/43

Sienna Cancer Diagnostics Ltd – scrip for scrip CGT roll-over relief following merger with BARD1 Life Sciences Ltd

This Ruling sets out the tax consequnces for Australian-resident Sienna Cancer Diagnostics Ltd shareholders who exchanged their shares for BARD1 Life Sciences Ltd shares.

This Ruling applies from 1 July 2020 to 30 June 2021.

 

Overview

The Commissioner of Taxation, Chris Jordan, has introduced two rulings under the Income Tax Assessment Act 1997. The purpose of these rulings is to provide clarity and guidance on specific tax issues arising from recent corporate activities. The first ruling, TR 2020/4, addresses the application of the arm’s length debt test in the context of thin capitalisation rules, which are designed to limit the deductions that can be claimed for debt-related interest where a company has an excessive level of debt relative to its equity. This ruling aims to ensure compliance with the principles of the arm’s length test, thereby maintaining the integrity of the tax system. The second ruling, CR 2020/42, outlines the tax implications for shareholders who received a return of capital from Nova Eye Medical Limited, providing them with essential information regarding their tax obligations in relation to this transaction. Both rulings are intended to be applied retroactively from their issuance, reinforcing the need for businesses and taxpayers to adhere to current tax laws.

Scope and Application

The rulings TR 2020/4, CR 2020/42, and CR 2020/43, issued by the Commissioner of Taxation, provide detailed guidance on specific aspects of income tax law, and apply to the respective transactions they describe. TR 2020/4 concerns the arm’s length debt test under the thin capitalisation rules in Division 820 of the Income Tax Assessment Act 1997, and applies to all entities subject to these rules, regardless of when the transactions in question occurred. CR 2020/42 addresses the tax consequences for shareholders of Nova Eye Medical Limited who received a return of capital, applying to transactions between 1 July 2020 and 30 June 2021. CR 2020/43 deals with capital gains tax roll-over relief for Australian-resident shareholders of Sienna Cancer Diagnostics Ltd who exchanged their shares for shares in BARD1 Life Sciences Ltd, applying to transactions within the same period. These rulings provide clarity on the tax treatment of specific transactions, ensuring taxpayers understand their obligations and entitlements under the relevant provisions of the Income Tax Assessment Act 1997.

Key Provisions

The key provisions of the two rulings issued by the Commissioner of Taxation focus on specific aspects of income tax related to corporate transactions. Ruling TR 2020/4 (section 820) addresses the application of the arm’s length debt test under the thin capitalisation rules. This ruling provides clarity on how these rules, which limit the amount of debt a company can have while maintaining a reasonable level of gearing, are applied. Essentially, it ensures that the level of debt a company can have is proportionate to its arm’s length debt, which is what an unrelated party would agree upon. This ruling is applicable both before and after its issuance, ensuring that taxpayers have consistent guidance on this matter. The rulings impose specific obligations on the entities and shareholders involved in these transactions. For instance, ruling CR 2020/42 requires shareholders who received a return of capital from Nova Eye Medical Limited on 29 July 2020 to understand the tax consequences of this transaction. This includes recognising the return of capital as assessable income and considering any associated deductions or credits. Similarly, ruling CR 2020/43 outlines the tax implications for Australian-resident shareholders of Sienna Cancer Diagnostics Ltd who exchanged their shares for shares in BARD1 Life Sciences Ltd. Shareholders must comply with the provisions regarding capital gains tax (CGT) roll-over relief, ensuring they correctly apply the rules to their transactions. There are specific consequences for non-compliance with these rulings. While the rulings themselves do not explicitly detail penalties, general tax laws provide for both civil and criminal penalties for non-compliance. For civil penalties, the Income Tax Assessment Act 1936 (ITAA 1936) outlines various penalties for failing to comply with tax laws, including penalties for providing false or misleading statements. In cases of criminal offences, the Criminal Code Act 1995 provides for more severe penalties, including fines and imprisonment, for serious tax evasion or fraud. Therefore, entities and individuals must ensure they adhere to the guidelines set out in these rulings to avoid potential legal repercussions.

Legal classification tags

Area of Law
Taxation Law
Instrument
Gazette Notice
Concepts
Definitions & Interpretation
Compliance Obligations
Offence Provisions

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.